Patent Assignment
Reel/Frame 053849/0967
Security Interest
Recorded: 2020-09-22
Pages: 14
Assignors
ADARE PHARMACEUTICALS, INC.
Executed: 2020-09-22
ADARE PHARMACEUTICALS USA, INC.
Executed: 2020-09-22
Assignee
CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
100 FEDERAL STREET, 31ST FLOOR, BOSTON, MASSACHUSETTS, 02109
Covered Properties
(52)
Controlled Release Oral Pharmaceutical Compositions
Application:
63/050,363 →
Orally Disintegrating Tablet Compositions of Lamotrigine
Orally Disintegrating Tablet Compositions of Lamotrigine
Orally Disintegrating Tablet Compositions of Lamotrigine
Orally Disintegrating Tablet Compositions of Lamotrigine
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Orally disintegrating tablets and methods of manufacture
Orally Disintegrating Tablets and Methods of Manufacture
Orally Disintegrating Tablets and Methods of Manufacture
Drug Delivery Systems Comprising Solid Solutions of Weakly Basic Drugs
Timed Pulsatile Drug Delivery Systems
Timed Pulsatile Drug Delivery Systems
Timed, Sustained Release Systems for Propranolol
Patent:
6,500,454 →
Application:
09/971,167 →
Timed, sustained release systems for propranolol
Timed, Sustained Release Systems for Propranolol
Pulsatile Release Histamine H2 Antagonist Dosage Form
Taste-Masked Pharmaceutical Compositions
Taste-Masked Pharmaceutical Compositions
Taste-Masked Pharmaceutical Compositions
Taste-Masked Pharmaceutical Compositions
Taste-Masked Pharmaceutical Compositions with Gastrosoluble Pore-Formers
Timed, pulsatile release systems
Timed, Pulsatile Release Systems
Timed, Pulsatile Release Systems
Timed, Pulsatile Release Systems
Timed, Pulsatile Release Systems
Timed, Pulsatile Release Systems
Timed, Pulsatile Release Systems
Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids
Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
Application:
12/956,543 →
Publication:
US US20110129530A1
Rapidly Dispersing Granules, Orally Disintegrating Tablets and Methods
Application:
13/310,632 →
Publication:
US US20120282335A1
Tizanidine Formulations
Application:
16/114,887 →
Publication:
US US20190060287A1
Oral Amphetamine Composition
Oral Amphetamine Composition
Swellable Dosage Form Comprising Gellan Gum
Swellable Dosage Form Comprising Gellan Gum
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics
Cysteamine Prodrugs
Extended-Release Drug Delivery Compositions
Application:
16/359,602 →
Publication:
US US20190216825A1
Biodegradable Polymer Microsphere Compositions for Parenteral Administration
Sustained Release Particle Formulations
Sustained Release Particle Formulations
Sustained Release Particle Formulations
Taste Masking Drug Formulations
Taste Masking Drug Formulations
Extended-Release Drug Delivery Compositions
Taste-Masked Pharmaceutical Compositions with Gastrosoluble Pore-Formers
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2010
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 023897/0180 →
Change of Name
Aug 30, 2012
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 028884/0903 →
Release of Lien on Patents
Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Assignment of Assignor's Interest
Dec 19, 2013
From: BOLTRI, LUIGI; COLOMBO, ITALO; FABIANI, FLAVIO; MAPELLI, LUIGI
To: APTALIS PHARMATECH, INC.
Reel/Frame 031820/0096 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Assignment of Assignor's Interest
Feb 19, 2014
From: VENKATESH, GOPI; LAI, JIN-WANG
To: APTALIS PHARMATECH INC
Reel/Frame 032244/0875 →
Assignment of Assignor's Interest
Mar 28, 2014
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 032550/0990 →
Change of Name
Mar 31, 2014
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 032568/0528 →
Assignment of Assignor's Interest
Jun 19, 2014
From: VENKATESH, GOPI M.; QIAN, KEN KANGYI; VANGALA, SHYAM; CLEVENGER, JAMES M.
To: EURAND PHARMACEUTICALS, LTD.
Reel/Frame 033141/0164 →
Change of Name
Jun 19, 2014
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 033212/0635 →
Change of Name
Jun 20, 2014
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 033205/0970 →
Change of Name
Jul 24, 2014
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 033406/0758 →
Assignment of Assignor's Interest
Jul 24, 2014
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 033383/0570 →
Change of Name
Jul 8, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036079/0791 →
Change of Name
Aug 5, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036283/0261 →
Change of Name
Sep 4, 2015
From: EURAND PHARMACEUTICALS LTD.
To: APTALIS PHARMA LIMITED
Reel/Frame 036554/0819 →
Change of Name
Sep 4, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036554/0829 →
Assignment of Assignor's Interest
Sep 4, 2015
From: APTALIS PHARMA LIMITED
To: APTALIS PHARMATECH, INC.
Reel/Frame 036495/0555 →
Assignment of Assignor's Interest
Sep 18, 2015
From: VENKATESH, GOPI M.; QIAN, KEN KANGYI; VANGALA, SHYAM; CLEVENGER, JAMES M.
To: EURAND PHARMACEUTICALS LTD.
Reel/Frame 036604/0134 →
Change of Name
Sep 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036640/0597 →
Change of Name
Sep 18, 2015
From: EURAND PHARMACEUTICALS LIMITED
To: APTALIS PHARMA LIMITED
Reel/Frame 036640/0595 →
Assignment of Assignor's Interest
Sep 18, 2015
From: APTALIS PHARMA LIMITED
To: APTALIS PHARMATECH, INC.
Reel/Frame 036604/0156 →
Change of Name
Sep 25, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036689/0358 →
U.S. Patent Security Agreement
Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →